text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "natural killer"

13 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • NK – Human Natural Killer Cells
    NK – Human Natural Killer Cells
    Human Natural Killer Cells pos selection, ≥5 million cells
    Catalog #: 2W-502
    Sales unit: each
    Compare
    EA
  • NK - Human Natural Killer Cells, Cryopreserved, Negative Selection, 5 Million
    NK - Human Natural Killer Cells, Cryopreserved, Negative Selection, 5 Million

    Crypreserved ampule of Peripheral Blood Human Natural Killer Cells (CD56 negative immunomagnetic selection) containing ≥ 5 million cells

    Catalog #: 2W-501
    Sales unit: each
    Compare
    EA
  • X-VIVO<sup>TM</sup> 15 Serum-free Hematopoietic Cell Medium
    X-VIVOTM 15 Serum-free Hematopoietic Cell Medium
    X-VIVO™ 15, Serum-free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree, 1 L
    Catalog #: 02-060Q
    Sales unit: each
    Compare
    EA
  • X-VIVO<sup>TM</sup> 15 Serum-free Hematopoietic Cell Medium
    X-VIVOTM 15 Serum-free Hematopoietic Cell Medium
    X-VIVO™ 15, Serum-free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree, 500mL
    Catalog #: 02-060F
    Sales unit: each
    Compare
    EA
  • Human Peripheral Blood CD4+ T Cells, Cryopreserved, 10 Million
    Human Peripheral Blood CD4+ T Cells, Cryopreserved, 10 Million

    Cryopreserved ampule of Human Peripheral Blood CD4+ T Cells containing ≥10 million cells, negatively selected.

    Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research

    Catalog #: 2W-200
    Sales unit: each
    Compare
    EA
  • Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million
    Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million

    Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells

    Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research

     

     

    Catalog #: CC-2702
    Sales unit: each
    Compare
    EA
  • Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 million
    Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 million

    Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells

    Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research

    Catalog #: CC-2703
    Sales unit: Ampule
    Compare
    AMP
  • Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 25 million
    Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 25 million

    Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 25 million cells

    Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research

    Catalog #: CC-2705
    Sales unit: Ampule
    Compare
    AMP
  • Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 10 million
    Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 10 million

    Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 10 million cells

    Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research

    Catalog #: CC-2704
    Sales unit: Ampule
    Compare
    AMP
  • Cryo Human Leukopak (9.5 Billion Cells)
    Cryo Human Leukopak (9.5 Billion Cells)

    Cryopreserved human leukapheresis product (≥9.5 billion cells)

    Catalog #: 260240.01
    Sales unit: Bag
    Compare
    BG
  • Cryo Human Leukopak (5.0 Billion Cells)
    Cryo Human Leukopak (5.0 Billion Cells)

    Cryopreserved human leukapheresis product (≥5.0 billion cells)

    Catalog #: 260260.01
    Sales unit: Bag
    Compare
    BG
  • Cryo Human Leukopak (2.5 Billion Cells)
    Cryo Human Leukopak (2.5 Billion Cells)
    Cryopreserved human leukapheresis product collected from normal peripheral blood, containing ≥2.5 billion cells
    Catalog #: 260280.01
    Sales unit: Bag
    Compare
    BG
  • Human Peripheral Blood CD8+ T Cells, Cryopreserved, 10 million cells
    Human Peripheral Blood CD8+ T Cells, Cryopreserved, 10 million cells

     Cryopreserved ampule of Human Peripheral Blood CD8+ T Cells containing 10 million cells

    Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research

     

    Catalog #: 2W-300
    Sales unit: Ampule
    Compare
    AMP

You searched for "natural killer"

637 Documents found
  • Natural Killer Cells Infographic
    Natural Killer cells have an innate ability to recognize and destroy non-self cells.
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • 3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
  • Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity Assay
    Protocol instructions
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
    A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • TechSheet - Poietics™ Human Immune System Cells
    Technical Product Information Sheet
  • References - X-Vivo™
    Overview of relevant references
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • Normal Peripheral Blood CD4+ T Lymphocytes
    Lonza Application Notes
  • Application Example
    Analysis of undirected migration of NK cells
  • TechSheet - X-VIVO™ Media Systems
    Instructions for how to use the X-VIVO™ Media Series
  • Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic Research
    Lonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
  • Non-viral Gene Modification for Ex-vivo Cell Therapy
    In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
  • Brochure - Cell List
    Integrated solutions for primary cells and transfection
  • Cell List – Integrated Solutions for Primary Cells and Transfection
  • Blood and Immune Cells
    Fueling your next discovery with unmatched cell and donor variety
  • Amaxa® Nucleofector® Technology - the Superior Non-Viral Method
    Lonza_Brochures_Amaxa_Nucleofector_Technology_-_the_Superior_Non-Viral_Method.pdf
  • 1(current)
  • 2
  • 3